Total DNA was extracted in triplicate from the suspension of each sample type using QIAamp DNA Mini Kit (Qiagen, Valencia, CA). Faecal samples (~200 mg) were resuspended in Qiagen’s ASL buffer and ...

QIAgen mini columns which included an on-column DNase step (Qiagen, UK) were used for the RNA purification as per manufacturer’s instruction. cDNA was prepared from RNA samples using the ...

PBMC were isolated from the same blood samples using density gradient centrifugation. PBMC gDNA was purified using the QIAamp DNA Mini Kit (Qiagen) following manufacturers instructions. Before ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further ...

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second ...

QIAGEN has now received regulatory clearances for three mini panels for detection of respiratory and gastrointestinal conditions, with these panels designed for outpatient use to aid fast and ...

The US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding the company’s syndromic testing offerings in the US.

QIAGEN building momentum in the U.S. syndromic testing market with six regulatory clearance of panels for use on QIAstat-Dx within the last 10 months GERMANTOWN, Md ...

VENLO, Netherlands, March 06, 2025--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx ...

The US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, ...